THE SGLT2 INHIBITOR EMPAGLIFLOZIN CAUSES A GREATER...

THE SGLT2 INHIBITOR EMPAGLIFLOZIN CAUSES A GREATER REDUCTION IN SKIN SODIUM CONTENT AND INTERSTITIAL VOLUME THAN LOOP DIURETICS IN HEART FAILURE

Santos-Gallego, Carlos G., Ibanez, Juan Antonio Requena, Antonio, Rodolfo San, Botija, Maria Belen Picatoste, Ishikawa, Kiyotake, Vahl, Torsten, Salvo, Angel Sanz, Fuster, Valentin, Badimon, Juan J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
75
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/S0735-1097(20)31702-2
Date:
March, 2020
File:
PDF, 227 KB
2020
Conversion to is in progress
Conversion to is failed